Actinium Pharmaceuticals reported $-16.64M in EBIT for its fiscal quarter ending in March of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Actinium Pharmaceuticals USD -16.64M 9.13M Mar/2025
Amgen USD 3.96B 464M Dec/2025
Bioline Rx USD -673K 2.99M Sep/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025
Pfizer USD 4.65B 71M Dec/2025